For the quarter ending 2026-03-31, CAI has $1,162,388K in assets. $568,898K in debts.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash | 821,147 | 797,799 | 754,739 | 720,444 |
| Short-term marketable securities | 2,315 | 2,295 | 2,272 | 2,249 |
| Accounts receivable | 90,517 | 112,140 | 26,697 | 50,889 |
| Supplies | 76,289 | 63,625 | 49,303 | 40,613 |
| Prepaid expenses and other current assets | 23,912 | 21,941 | 21,234 | 19,124 |
| Total current assets | 1,014,180 | 997,800 | 854,245 | 833,319 |
| Property and equipment, net | 82,669 | 63,170 | 63,997 | 61,315 |
| Goodwill | 19,344 | 19,344 | 19,344 | 19,344 |
| Other assets | 46,195 | 45,349 | 46,985 | 41,080 |
| Total assets | 1,162,388 | 1,125,663 | 984,571 | 955,058 |
| Accounts payable | 69,802 | 39,206 | 28,999 | 28,728 |
| Accrued expenses and other current liabilities | 73,921 | 87,770 | 56,867 | 61,357 |
| Current portion of indebtedness | 173 | 169 | 164 | 95 |
| Total current liabilities | 143,896 | 127,145 | 86,030 | 90,180 |
| Long-term indebtedness, net of debt discounts | 381,402 | 378,823 | 376,296 | 373,611 |
| Warrant liabilities | - | 0 | 0 | 0 |
| Other long-term liabilities | 43,600 | 42,388 | 43,881 | 38,363 |
| Total liabilities | 568,898 | 548,356 | 506,207 | 502,154 |
| Redeemable convertible preferred stock-Series APreferred Stock | - | 0 | 0 | 0 |
| Redeemable convertible preferred stock-Series BPreferred Stock | - | 0 | 0 | 0 |
| Redeemable convertible preferred stock-Series CPreferred Stock | - | 0 | 0 | 0 |
| Redeemable convertible preferred stock-Series DPreferred Stock | - | 0 | 0 | 0 |
| Redeemable convertible preferred stock | - | 0 | 0 | 0 |
| Preferred stock | 0 | 0 | - | - |
| Common stock | 284 | 283 | 283 | 282 |
| Treasury stock | 16,896 | 16,896 | 16,917 | 16,917 |
| Additional paid-in capital | 3,158,455 | 3,141,720 | 3,124,943 | 3,123,888 |
| Related party promissory note receivable (see note 7) | - | 0 | 0 | 0 |
| Accumulated deficit | -2,549,246 | -2,548,736 | -2,630,693 | -2,655,018 |
| Accumulated other comprehensive income | 893 | 936 | 748 | 669 |
| Total shareholders' equity | 593,490 | 577,307 | 478,364 | 452,904 |
| Total liabilities and shareholders' equity | 1,162,388 | 1,125,663 | 984,571 | 955,058 |
Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc. (CAI)